Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Retail Hiring Surge in April Contrasts with Consumer Caution Signals CVS Caremark to Cover Eli Lillys GLP1 Drugs Foundayo and Zepbound Expanding Access for Millions David Archuletas Bestselling Memoir Devout Spurs Publishing Sector Interest in Faith and Identity Narratives UK Exports to US Plunge 25 Following Trump Liberation Day Tariffs UK Now Faces Trade Deficit with Largest Partner Companies Remain Committed to Prediction Markets Amid Regulatory Uncertainty King Yuan Electronics Expands Global Presence with New Singapore Facility Targeting 300 Jobs AMTD Q4 2020 Earnings EPS Surges Past Estimates Stock Reacts with Modest Decline BRC Group Holdings Inc 550 Senior Notes Due 2026 RILYK Q1 2024 Earnings Net Loss Widens Bond Prices Edge Higher LUNR Q1 2026 Earnings Significant EPS Miss as Revenue Remains Unreported AEHL Q3 2012 Earnings EPS Beats Estimates by 768 Stock Falls Sharply LyondellBasell LYB Q1 2026 Earnings Surprise EPS Beat Fails to Lift Shares as Market Focuses on Demand Concerns PROV Q1 2026 Earnings EPS Misses Estimates by 336 Stock Rises Marginally ProFrac Holding Corp ACDC Edges Lower Amid Consolidation Pressures Weyerhaeuser WY Holds Near Support Amid Modest Gains Nuveen AMTFree Municipal Credit Income Fund NVG Edges Higher Amid Steady Trading Old Republic International ORI Slips 26 as Support Levels Come into Focus Artius II Acquisition Inc AACB Holds Steady Near NAV as Market Awaits Business Combination Fifth District Bancorp FDSB Edges Higher as Support Holds Steady NextPlat Corp NXPL Surges 227 as Strong Buying Pressure Drives Price Above Key Support Castor Maritime CTRM Slides 455 to 189 as Selling Pressure Mounts ATIF Holdings ZBAI Holds Flat at 895 as Traders Assess Key Levels Adial Pharmaceuticals ADIL Drops 957 as Selling Pressure Mounts Near Key Support Fennec Pharmaceuticals FENC Holds Steady Near Support as Investors Assess Outlook